XML 44 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings per Share
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings per Share

22. Earnings per Share

The following table sets forth the computation of basic and diluted income attributable to common shareholders of Sinovac per share (in thousands, except for number of shares and per share data):

 

 

 

 

For the year ended December 31

 

 

 

 

2022

 

 

2021

 

 

2020

 

 

Numerator

 

 

 

 

 

 

 

 

 

 

Net income

 

$

88,131

 

 

$

14,458,911

 

 

$

185,179

 

 

Less: Income (loss) attributable to non-controlling interests

 

 

(25,735

)

 

 

5,991,431

 

 

 

74,810

 

 

Income attributable to shareholders of Sinovac

 

 

113,866

 

 

 

8,467,480

 

 

 

110,369

 

 

Less: Preferred stock dividends

 

 

5,982

 

 

 

5,982

 

 

 

6,015

 

 

Net income attributable to shareholders of Sinovac

 

 

107,884

 

 

 

8,461,498

 

 

 

104,354

 

 

Net income attributable to shareholders of Sinovac for computing diluted net income per share

 

 

113,866

 

 

 

8,467,480

 

 

 

110,369

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

Basic weighted average number of common shares outstanding

 

 

99,502,243

 

 

 

99,311,551

 

 

 

98,897,345

 

 

Dilutive effect of stock options and preferred shares

 

 

14,670,539

 

 

 

14,694,432

 

 

 

14,765,017

 

 

Diluted weighted average number of common shares outstanding

 

 

114,172,782

 

 

 

114,005,983

 

 

 

113,662,362

 

 

Earnings per share

 

 

 

 

 

 

 

 

 

 

Basic net income per share

 

 

1.08

 

 

 

85.20

 

 

 

1.06

 

 

Diluted net income per share

 

 

1.00

 

 

 

74.27

 

 

 

0.97

 

 

As the Company announced on February 22, 2019, the Company’s Board of Directors determined that certain shareholders became Acquiring Persons, and a Trigger Event occurred under the Rights Agreement. As a result, 27,777,341 new common and 14,630,813 preferred shares of the Company were issued into a trust for the benefit of the holders of the valid and outstanding Rights. Releasing these shares from the trust is contingent on an outcome from the Company's legal proceeding in Antigua (Note 18). Without the effect of the implementation of the Rights Agreement and the newly issued common and preferred shares, basic weighted average number of common shares outstanding and diluted weighted average number of common shares outstanding would be 71,724,902 and 71,764,628, respectively. And the basic and diluted earnings per share for 2022 would be $ 1.59.